October 2016

Review
Measurements of Medication Adherence: In Search of a Gold Standard
Eugene Kreys, PharmD, PhD, BCPS

J Clin Pathways. 2016;2(8):43-47.
Received July 18, 2016; accepted September 13, 2016.

Departments

Editor's Page
Accounting for Patient Differences in the Pathway
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2017;2(8):7.

Research in Review
Infectious Disease Specialists Propose Clinical Pathway for ABSSI
JCP Editors

J Clin Pathways. 2017;2(8):8-13.

Research in Review
Pembrolizumab More Cost Effective Than Docetaxel for PD-L1-Positive NSCLC
JCP Editors

J Clin Pathways. 2017;2(8):8-13.

Research in Review
MicroRNA a Novel Biomarker for Gastric Cancer
JCP Editors

J Clin Pathways. 2017;2(8):8-13.

Research in Review
Mixed Consensus on Cardiovascular Screening Guidelines
JCP Editors

J Clin Pathways. 2017;2(8):8-13.

Interview
COA Speaks Out Against PBM Restrictions of Medication Access
JCP Editors

J Clin Pathways. 2016;2(8):26-28.

Interview
Pathways for Cancer Survivors
JCP Editors

J Clin Pathways. 2016;2(8):22-25.

Columns

Pharma Insights
Formulary Exclusion Lists Create Challenges for Pharma and Payers Alike
Andrew Cournoyer, RPh, MBA; Larry Blandford, PharmD—Column Editor

J Clin Pathways. 2016;2(8):33-34.

Clinical Pathways GPS
The Future of Clinical Pathways: The Potential Impact of the Presidential Election
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Scott Guerin, PhD

J Clin Pathways. 2016;2(8):29-31.

Features

From the Field
A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways
Rahma Warsame, MD; Joleen Hubbard, MD; Angela Dispenzieri, MD; Carrie Thompson, MD; Katrina Croghan, MS; Juliana Perez Botero, MD; Angelina Tan; Briant Fruth; Deirdre Pachman, MD; Veronica Lafky; Jeff Sloan, PhD

J Clin Pathways. 2016;2(8):35-41.
Received August 11, 2016; accepted September 20, 2016.

Back to Top